Cargando…

Infecciones transmitidas por el donante

The defence response to infectious agents is compromised in solid organ recipients because of their immunosuppressive treatment. Transmission of infection from a donor organ can result in dysfunction or loss of the allograft, and may lead to death of the recipient if adequate preventive measures are...

Descripción completa

Detalles Bibliográficos
Autores principales: Len, Óscar, Pahissa, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España S.L. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130243/
https://www.ncbi.nlm.nih.gov/pubmed/17335701
http://dx.doi.org/10.1016/S0213-005X(07)74262-3
_version_ 1783516966527434752
author Len, Óscar
Pahissa, Albert
author_facet Len, Óscar
Pahissa, Albert
author_sort Len, Óscar
collection PubMed
description The defence response to infectious agents is compromised in solid organ recipients because of their immunosuppressive treatment. Transmission of infection from a donor organ can result in dysfunction or loss of the allograft, and may lead to death of the recipient if adequate preventive measures are not taken. This potential risk should be thoroughly assessed, particularly in the case of organs from infected donors, in order to optimize organ use without increasing the incidence of graft dysfunction and recipient morbidity and mortality. This article reviews the current knowledge regarding screening for infection in potential donors and discusses risk-benefit considerations related to the use of organs from infected donors.
format Online
Article
Text
id pubmed-7130243
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier España S.L.
record_format MEDLINE/PubMed
spelling pubmed-71302432020-04-08 Infecciones transmitidas por el donante Len, Óscar Pahissa, Albert Enferm Infecc Microbiol Clin Article The defence response to infectious agents is compromised in solid organ recipients because of their immunosuppressive treatment. Transmission of infection from a donor organ can result in dysfunction or loss of the allograft, and may lead to death of the recipient if adequate preventive measures are not taken. This potential risk should be thoroughly assessed, particularly in the case of organs from infected donors, in order to optimize organ use without increasing the incidence of graft dysfunction and recipient morbidity and mortality. This article reviews the current knowledge regarding screening for infection in potential donors and discusses risk-benefit considerations related to the use of organs from infected donors. Elsevier España S.L. 2007-03 2009-01-06 /pmc/articles/PMC7130243/ /pubmed/17335701 http://dx.doi.org/10.1016/S0213-005X(07)74262-3 Text en Copyright © 2007 Elsevier España S.L. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Len, Óscar
Pahissa, Albert
Infecciones transmitidas por el donante
title Infecciones transmitidas por el donante
title_full Infecciones transmitidas por el donante
title_fullStr Infecciones transmitidas por el donante
title_full_unstemmed Infecciones transmitidas por el donante
title_short Infecciones transmitidas por el donante
title_sort infecciones transmitidas por el donante
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130243/
https://www.ncbi.nlm.nih.gov/pubmed/17335701
http://dx.doi.org/10.1016/S0213-005X(07)74262-3
work_keys_str_mv AT lenoscar infeccionestransmitidasporeldonante
AT pahissaalbert infeccionestransmitidasporeldonante